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Recent studies have shown that increased cognitive intraindividual variability (IIV) across
accuracy scores from tests representing different cognitive domains (across-domain IIV)
might indicate prodromal Alzheimer’s disease (AD). Although IIV has been proposed to
index cognitive control processes, IIV across accuracy scores from cognitive control tasks
(within-domain IIV) has not been examined in healthy controls subjects (HCS),mild cognitive
impairment (MCI), and AD patients in a single comparative study. This study examines
the discriminative properties of within-domain IIV, and across-domain IIV in 149 HCS, 31
MCI, and 26 AD. Three tasks representing different cognitive domains were identiﬁed to
calculate across-domain IIV.Three other tasks representing cognitive control were identiﬁed
to calculate within-domain IIV. The intraindividual standard deviation was calculated across
accuracy scores. To compare IIV between groups, ANCOVAs with the covariates age,
gender, education, and mean performance were computed. IIV scores in general were
higher in AD vs. HCS (p < 0.01). Only across-domain IIV was higher in AD vs. MCI
(p = 0.001), and only within-domain IIV was higher in MCI vs. HCS (p = 0.05). Within-
domain IIV may constitute a cognitive marker for the detection of prodromal AD at the MCI
stage, whereas across-domain IIV may detect beginning AD at the MCI stage.
Keywords:Alzheimer’s disease, mild cognitive impairment, early diagnosis, cognitive control, cognitive variability,
neuropsychology
INTRODUCTION
The importance of reliable methods for the early detection
of Alzheimer’s disease (AD) has increased with the expected
availability of treatment methods, which may be most efﬁca-
cious in preclinical (Masdeu et al., 2012) or early disease stages
(Doraiswamy et al., 2002). Cognitive intraindividual variability
(IIV) has evidenced representing a potential marker of early
cognitive impairment (MacDonald et al., 2009), with IIV across
multiple trials of a reaction time (RT) task or across different
RT tasks (latency-based IIV) predicting global decline (Hultsch
et al., 2002; Lövdén et al., 2007) and being increased in mild cog-
nitive impairment (MCI; Duchek et al., 2009; McLaughlin et al.,
2010), andAD (Hultsch et al., 2000; Jackson et al., 2012). However,
integrating repetitive RT tasks into already existing comprehen-
sive test batteries may increase the testing-associated burden on
patients.
Considering IIV across accuracy scores of different cognitive
tasks (accuracy-based IIV) may provide an alternative. Although
latency- and accuracy-based IIV have reportedly been associ-
ated (Hultsch et al., 2002; Hilborn et al., 2009), the latter has
not been studied extensively. However, the use of accuracy-based
IIV across tests representing different cognitive domains (across-
domain IIV) appears promising for predicting global (Kliegel
and Sliwinski, 2004) and functional decline (Morgan et al., 2012),
incident dementia (Holtzer et al., 2008), and probable AD (Brew-
ster et al., 2012). Likewise, it was found to be increased in MCI
and AD (Tractenberg and Pietrzak, 2011; MacDonald et al., 2012).
Although IIV has been proposed to index cognitive control pro-
cesses supported by the frontal cortex (MacDonald et al., 2009),
accuracy-based IIV across tests representing cognitive control
functions (within-domain IIV) to our knowledge has not been
examined in healthy control subjects (HCS), MCI, and AD in
a single comparative study. Consequently, the aim of our study
was to investigate within- and across-domain IIV as markers for
prodromal AD. We compared IIV between groups and hypoth-
esized increased levels in MCI and AD. Additionally, and since
the apolipoprotein E (APOE) ε4 allele represents a risk factor
for late-onset AD (Corder et al., 1993; Petersen et al., 1995; Tang
et al., 1996), we explored the relationship between IIV and APOE
genotype.
MATERIALS AND METHODS
STUDY POPULATION
A total of 267 subjects (HCSn= 180,MCIn= 44,ADn= 26) from
on-going studies at the Memory Clinic of the Division of Psychi-
atry Research and Psychogeriatric Medicine, University of Zurich,
were considered for cross-sectional baseline analysis. Participants
were recruited from the outpatient population of the Memory
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Clinic or by advertisement in the local media. All subjects had
complete cognitive baseline data acquired between January 2006
and May 2012.
Mild cognitive impairment was diagnosed according to
Winblad et al. (2004). AD subjects met NINCDS-ADRDA (McK-
hann et al., 1984) criteria for probableAD.All diagnosesweremade
by a multidisciplinary team under the supervision of an experi-
enced psychiatrist. HCS were required to be cognitively healthy
and report cognitive well-being. MCI and AD subjects were
excluded from the present analyses if there was evidence for the
use of psychoactive medication, abuse of alcohol and drugs, other
past or present psychiatric or neurological diseases or signiﬁcant
other systemic diseases, or structural abnormalities in the brain
assessed by magnetic resonance imaging (MRI) that could account
for the cognitive decline. Additionally, HCS were excluded if there
was signiﬁcant medical disease, clinically signiﬁcant depression or
any medication use potentially affecting cognition. Visits included
screenings for depression, psychiatric, neurological, and internal
diseases, and other disorders that could potentially produce cogni-
tive impairment. The neuropsychological test battery consisted of
multiple tests covering the following cognitive domains: episodic
memory, executive function, attention/psychomotor processing
speed, language, and visual-constructive abilities. Impairment was
deﬁned if at least one score per domain was 1.5 SD below group
means provided by test-speciﬁc normative data.
From the original HCS sample, 31 subjects were excluded
from the analyses due to clinically signiﬁcant neurological dis-
ease (n = 3), alcohol abuse (n = 1), medication (n = 25), and due
to dropout after the assessment (n = 2). Due to a change in test
batteries, 13 MCI subjects were missing a test score relevant for
computing IIV and were excluded from the analyses. Thus, a total
of 149 HCS, 31 MCI patients, and 26 patients with probable AD
were eligible for the current analysis of IIV. The ﬁnal demographic
details are presented in Table 1. This study was approved by the
cantonal ethics committee of cantonZurich, Switzerland, in accor-
dance with the Helsinki Declaration. All participants and/or their
legal representatives provided written informed consent prior to
study inclusion.
COMPUTATION OF INTRAINDIVIDUAL VARIABILITY
Considering the clinical applicability of the IIV scores, we retro-
spectively identiﬁed tasks with less than 1% missing values per
diagnostic group. Additionally, we only selected tasks with no ceil-
ing or ﬂoor effects to prevent suppressing variation at the extreme
ends of the distribution.
For calculating across-domain IIV, we used accuracy scores
from three tests, each representing a different cognitive domain:
Digit Span Forward from the Wechsler Memory Scale-Revised
(Härting et al., 2000), assessing verbal short-term memory capac-
ity (Lezak et al., 2004), Word List Learning and Category Fluency
from the CERAD-plus test battery (Thalmann et al., 1997) assess-
ing verbal learning and executive function/semantic knowledge,
respectively. For calculating within-domain IIV, we used accu-
racy scores from three tests, each representing executive functions
and eliciting recruitment of cognitive control processes. The Let-
ter Fluency test requires participants to name as many words
as possible within 3 min while taking into account particular
restrictions (i.e., no names, geographically related words, labels,
repetitions). Participants need to generate, maintain, and monitor
a plan, to select and establish speciﬁc responses and, therefore,
access cognitive control (Stein et al., 2010; Reiman et al., 2014).
Compared with the Category Fluency test, which consists of a
single restriction (name animals) and is of a shorter duration
(1 min), the Letter Fluency test represents a more complex task.
Increasing task complexity is thought to place higher demands
on higher order cognitive abilities (Halford et al., 2005) such as
cognitive control processes. Accordingly, the Letter Fluency test
is thought to rely more on cognitive control processes but less
on semantic knowledge than the Category Fluency task (Delis
and Kaplan, 2001). Trial 3 from the Stroop Test (Troyer et al.,
2006) requires subjects to accurately name the color in which
24 non-congruent color words are printed (i.e., the word blue
is printed in red color). Accordingly, participants need to main-
tain a goal while inhibiting a routine response in favor of a less
familiar one, a process which typically involves cognitive control
(West et al., 2002). The Five-Point Test (Regard et al., 1982) rep-
resents ﬁgural ﬂuency and requires participants to draw as many
different ﬁgures as possible within 3 min by connecting dots dis-
playing the ﬁve-dot arrangement on dice. Participants, therefore,
need to follow a mental strategy and monitor their performance.
This coordination of information to select appropriate behavioral
responses represents aspects of cognitive control (Kelemen and
Fenton, 2010).
The simplest method to compute IIV is to calculate the intrain-
dividual standard deviation (ISD; Nesselroade and Salthouse,
2004) across each individual’s accuracy scores. Before comput-
ing ISD, two missing Stroop Test raw scores in HCS and MCI
were imputed with the expected-maximization algorithm in SPSS.
Effects associated with age, education, and gender, and potential
interactions were estimated from the HCS’ raw scores by using
General Linear Model. Parameters for age, education, and gender
from this model were used to predict accuracy scores in both MCI
and AD subjects. Standardized residuals for MCI and AD were
then calculated by subtracting the predicted from the observed
accuracy scores and dividing it by the model’s standard error.
Residuals from the Stroop Test were log-transformed to achieve
normal distribution, and multiplied by −1 to adjust for scaling
difference. In sum, this procedure generated standardized residu-
als representing adjusted accuracy scores with a mean of 0 and
variance of ∼1 in HCS. By restricting the variance to ∼1 in
HCS, we lowered the risk of overestimating IIV in HCS due to
higher mean performance, since ISD is not independent from
the mean (Allaire and Marsiske, 2005). Accordingly, residuals
deviating from 0 represented adjusted accuracy scores for MCI
and AD subjects. We then computed ISD across each individual’s
residuals on Digit Span Forward, Word List Learning, and Cate-
gory Fluency representing across-domain IIV, whereas ISD across
residuals on Letter Fluency, Stroop Test, and Five-Point Test rep-
resented within-domain IIV. To further address the association
between ISD and mean performance, we used the intraindivid-
ual mean (IIM) across residuals underlying across-domain IIV
(across-domain IIM) and across residuals underlying within-
domain IIV (within-domain IIM) as covariates in all relevant
analyses.
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Table 1 | Demographic information and cognitive measures per diagnostic group.
Characteristic HCS MCI AD pValue
N 149 31 26 N/A
Age, y 68.93 (5.75) 73.39 (5.93) 77.65 (6.10) 0.000*a,b,c
Gender, M/Fd 59/90 11/20 7/19 0.455
Years of education 14.51 (3.25) 12.94 (2.95) 11.12 (2.81) 0.000* a,b
MMSEe 29.43 (0.82) 27.87 (1.77) 21.46 (3.78) 0.000* a,b,c
Digit Span Forward raw 7.49 (1.78) 5.90 (1.33) 5.35 (1.81) N/A
res 0.00 (0.99) −0.63 (0.71) −0.65 (1.16) 0.000* a,b
Word List Learning raw 23.70 (2.87) 17.13 (4.49) 12.27 (4.01) N/A
rese 0.00 (0.99) −2.25 (1.58) −3.91 (1.43) 0.000* a,b,c
Category Fluency raw 23.91 (4.74) 17.71 (5.10) 11.08 (5.25) N/A
res 0.00 (0.99) −1.22 (1.08) −2.53 (1.15) 0.000* a,b,c
Letter Fluency raw 31.65 (8.93) 22.58 (10.21) 13.23 (5.96) N/A
res 0.00 (0.99) 0.29 (1.52) −0.66 (1.12) 0.004* a,c
StroopTrial 3 raw 28.36 (8.70) 35.29 (9.94) 69.04 (48.33) N/A
rese 0.00 (0.99) −0.74 (1.01) −2.74 (2.20) 0.000* a,b,c
Five−Point Test raw 25.96 (7.00) 18.74 (6.70) 12.19 (5.27) N/A
res 0.00 (0.99) −0.91 (0.87) −1.70 (0.78) 0.000* a,b,c
Across-domain IIM 0.00 (0.63) −1.37 (0.82) −2.36 (0.92) 0.000* a,b,c
Within-domain IIM 0.00 (0.73) −0.45 (0.86) −1.70 (0.99) 0.000* a,b,c
Across-domain IIVf 0.91 (0.62) 0.98 (0.58) 1.52 (0.75) 0.001* a,c
Within-domain IIVf 0.75 (0.55) 1.01 (0.52) 1.23 (0.65) 0.002* a,b
HCS = healthy control subjects; MCI = mild cognitive impairment; AD = Alzheimer’s disease; N/A = not applicable; MMSE = Mini-Mental State Examination;
res = standardized residuals; raw = raw scores; IIM = intraindividual mean; IIV = intraindividual variability. Data are means and standard deviations unless speciﬁed
otherwise. Standardized residuals of cognitive test scores for MCI and AD were calculated by using parameter estimates for age, education and gender in HCS.
*Signiﬁcant global p value test by analysis of variance unless speciﬁed otherwise. Post hoc tests indicated signiﬁcant differences at p ≤ 0.05 or lower (parametric
tests) and p < 0.01 or lower (non-parametric tests) for aHCS vs. AD; bHCS vs. MCI; cMCI vs. AD. dPearson’s X
2 test. eKruskal–Wallis test followed by Mann–Whitney
test. fAnalyses of covariance, means adjusted for age, gender, education and across- or within-domain IIM.
GENOTYPING
Apolipoprotein E genotyping was performed by restriction iso-
typing as described previously (Hixson and Vernier, 1990). For
analysis, participantswere classiﬁed as either carriers (APOE ε2/ε4,
ε3/ε4 and ε4/ε4) or non-carriers of the APOE ε4 allele.
STATISTICS
Group comparisons of normally distributed demographic data,
raw and adjusted cognitive data were applied using univariate
analysis of variance (ANOVA) followed by Sidak post hoc tests cor-
recting for multiple comparisons. Kruskal–Wallis tests followed
by Mann-Whitney tests corrected for multiple comparisons were
performed to compare not normally distributed variables. Pear-
son’s chi-square test was used for categorical variables. Univariate
analyses of covariance (ANCOVA) with diagnostic group treated
as the main effect were performed to evaluate group wise differ-
ences in across- and within-domain IIV. Although inﬂuences of
age, gender and education had already been taken into account
while computing IIV, they were used as covariates to control for
inﬂuences on IIV. Across- and within-domain IIM represented
additional covariates. Sum of Square Type III was applied to take
into account the unbalanced design. Signiﬁcant group effects were
further examined using Sidak post hoc test correcting for multiple
comparisons. For parametric analyses, tests were performed with
a signiﬁcance level of p < 0.05. Manually correcting for multiple
comparisons, a signiﬁcance level of p< 0.017 (0.05/3 = 0.017) was
applied for non-parametric analyses. All analyses were performed
as two-sided tests by using the statistical analysis software package
PASW 19.0 for Windows.
RESULTS
Descriptive statistics for demographic information and adjusted
cognitive data, as well as cognitive raw data is listed in Table 1.
Across-domain IIV was inﬂuenced by age [F(1,199) = 3.958;
p = 0.048; η2p = 0.020], and slightly by across-domain IIM
[F(1,199) = 3.520; p = 0.062; η2p = 0.017] but not by edu-
cation [F(1,199) = 0.076; p = 0.783; η2p = 0.000] or gender
[F(1,199) = 1.346; p = 0.247; η2p = 0.007]. But ﬁrst and fore-
most we observed a main effect between the diagnostic groups
[F(2,199) = 7.310; p = 0.001; η2p = 0.068]. Patients with AD
revealed higher IIV than HCS (p = 0.002; 95% CI = 0.192–
1.030) and MCI (p = 0.001; 95% CI = 0.170–0.892), whereas
IIV did not differ between MCI and HCS (p = 0.896; 95%
CI = –0.226–0.387; Figure 1A). Within-domain IIV was not
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FIGURE 1 | Comparison of intraindividual variability (IIV) scores
between diagnostic groups. Intraindividual standard deviation (ISD)
representing mean across-domain IIV (A) and mean within-domain IIV (B)
per diagnostic group (HCS = healthy control subjects; MCI = mild cognitive
impairment; AD = Alzheimer’s disease). Error bars display 95% conﬁdence
interval for the mean. Pairwise p values shown are based on Sidak post
hoc tests following analyses of covariance for the comparison of means
adjusted for age, years of education, gender, as well as mean
across-domain performance (A) and mean within-domain performance (B),
respectively.
inﬂuenced by age [F(1,199) = 0.054; p = 0.816; η2p = 0.000],
education [F(1,199) = 2.237; p = 0.136; η2p = 0.011), gender
[F(1,199) = 2.613; p = 0.108; η2p = 0.013] or within-domain IIM
[F(1,199) = 1.500; p = 0.222; η2p = 0.007], but differed among
diagnostic groups [F(2,199) = 6.330; p = 0.002; η2p = 0.060].
IIV was higher in AD than HCS (p = 0.004; 95% CI = 0.126–
0.825). But contrary to across-domain IIV, within-domain IIV
was similar in AD and MCI (p = 0.374; 95% CI = 0.142–
0.582). More importantly, there was a strong trend for higher
IIV in MCI than in HCS (p = 0.055; 95% CI = –0.004–0.514;
Figure 1B).
To evaluate whether there was a relationship between IIV
scores, a difference score was calculated by subtracting within-
from across-domain IIV. ANCOVA was performed by treating
age, education, gender, and across- and within-domain IIM as
covariates. The effect of diagnostic group did not approach sig-
niﬁcance [F(2,198) = 1.497; p = 0.226; η2p = 0.015], indicating
similar differences between IIV scores across diagnostic groups.
The qualitative analysis of difference scores, however, revealed
positive difference scores within each group (HCS: M = 0.141,
SD = 0.805; MCI: M = 0.005, SD = 0.757; AD: M = 0.340,
SD = 0.989), indicating a tendency toward higher across- than
within-domain IIV in these groups.
The relationship between APOE status and IIV was explored
in a subsample with available genotype. Descriptive statistics for
demographic information and adjusted cognitive data is listed in
Table 2.
To compare IIV scores between ε4 carrier and non-carrier
within each group, we performed ANCOVAs by treating gender
as a covariate in MCI. Across-domain IIV did not vary with APOE
status in HCS [F(1,111) = 0.368; p = 0.545; η2p = 0.003], MCI
[F(1,27) = 0.227; p = 0.638; η2p = 0.008] or AD [F(1,21) = 0.003;
p = 0.957; η2p = 0.000]. Likewise, within-domain IIV did not vary
as a function of APOE status in MCI [F(1,27) = 0.348; p = 0.560;
η2p = 0.013] or AD [F(1,21) = 0.149; p = 0.703; η2p = 0.007].
In HCS, however, there was a weak though signiﬁcant effect of
APOE status [F(1,111) = 3.972; p = 0.049; η2p = 0.035] indicating
increased within-domain IIV in ε4 carrier.
DISCUSSION
This study examined whether two different accuracy-based
IIV measures on established neuropsychological tasks differed
between HCS, MCI, and AD. Our results suggest an increasing
breakdown of cognitive control functions early in prodromal AD
resulting in increased IIV. More precisely, across- and within-
domain IIV, as used in the present study, may differ from each
other as a function of cognitive control required by the underly-
ing tasks. Within-domain IIV tapping cognitive control functions
more closely was increased in AD and MCI vs. HCS, and appears
to constitute a potential marker for the detection of prodromal
AD at the MCI stage. Across-domain IIV tapping less cognitive
control functions was increased in AD vs. MCI and HCS, and may
detect incipient dementia and separate AD from the MCI stage.
The establishment of cognitive markers that accurately predict
the diagnosis of AD and its preclinical manifestation MCI, sup-
ports the effort of early detection. Mean performance in tests of
verbal episodic memory (Derby et al., 2013) and executive func-
tion (Schroeter et al., 2012) in particular are known markers for
predicting AD. The reliable detection of early cognitive impair-
ment based on mean cognitive performance in clinical routine,
however, poses a challenge. Most importantly, cognitive changes
in subjectswith high educational backgroundmay be present prior
to a clinical diagnosis but may be very subtle, and therefore may be
undetected. Cognitive measures that discriminate between MCI
due to AD and HCS based on abilities relevant to everyday life
(i.e., Bird et al., 2010) might further support the reliable early
detection, but such tests have not been under ample investigation.
Across- andwithin-domain IIVwas found to be independent from
the mean cognitive performance, and might therefore represent a
more sensitive early marker of cognitive impairment than mean
cognitive performance.
Although it represents an easy to use measure in clinical rou-
tine (Holtzer et al., 2008) only few studies have investigated IIV
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Table 2 | Demographic information and cognitive measures per diagnostic group andAPOE genotype.
Characteristic HCS MCI AD pValue
APOE status ε4+ ε4− ε4+ ε4− ε4+ ε4− N/A
Nc 26 87 16 14 9 14 0.004*
Age, y 71.04 (5.92) 68.89 (5.72) 73.31 (6.44) 73.36 (5.75) 77.33 (3.87) 78.07 (7.43) −
Gender, M/Fd 11/15 39/48 2/14 9/5 4/5 3/11 0.003*a
Years of education 14.77 (2.89) 14.72 (3.52) 12.44 (2.78) 13.57 (3.23) 10.67 (2.18) 10.93 (3.17) −
MMSE 29.23 (0.91) 29.47 (0.83) 27.44 (1.50) 28.21 (1.97) 20.56 (3.40) 21.86 (4.11) −
Digit Span forward 0.02 (1.14) −0.008 (1.03) −0.61 (0.67) −0.58 (0.74) −0.37 (1.34) −0.57 (0.99) −
Word List Learning −0.06 (0.94) 0.05 (1.07) −2.23 (1.61) −2.14 (1.58) −3.78 (1.68) −3.99 (1.47) −
Category Fluency 0.33 (0.99) −0.06 (1.01) −1.37 (0.94) −0.89 (1.11) −2.39 (1.42) −2.63 (1.04) −
Letter Fluency 0.57 (1.16) −0.11 (0.88) 0.65 (1.13) −0.17 (1.83) −1.29 (1.33) −0.39 (0.88) 0.002*b
StroopTrial 3 0.02 (0.94) 0.07 (1.04) −0.94 (0.86) −0.44 (1.12) −2.78 (2.01) −2.95 (2.45) −
Five-Point Test 0.25 (1.00) −0.05 (0.97) −1.03 (0.61) −0.77 (1.12) −1.71 (0.97) −1.77 (0.75) −
Across-domain IIM 0.09 (0.61) 0.00 (0.68) −1.41 (0.80) −1.20 (0.77) −2.18 (1.26) −2.39 (0.77) −
Within-domain IIM 0.28 (0.72) −0.02 (0.72) −0.44 (0.64) −0.46 (1.12) −1.93 (1.01) −1.70 (1.00) −
Across-domain IIVe 0.91 (0.46) 0.84 (0.44) 1.03 (0.81) 1.18 (0.22) 1.86 (0.59) 1.84 (0.87) −
Within-domain IIVe 0.86 (0.40) 0.68 (0.41) 0.97 (0.47) 1.08 (0.05) 1.33 (0.72) 1.51 (1.22) 0.049*b
HCS = healthy control subjects; MCI = mild cognitive impairment; AD =Alzheimer’s disease; ε4+ = ε4 carrier; ε4− = ε4 non-carrier; N/A = not applicable; MMSE = Mini-
Mental State Examination; IIM = intraindividual mean; IIV = intraindividual variability. Data are means and standard deviations unless speciﬁed otherwise. Standardized
residuals of cognitive test scores for MCI and AD were calculated by using parameter estimates for age, education and gender in HCS. * If not stated otherwise:
Signiﬁcant p value test by analysis of variance per diagnostic group indicated signiﬁcant differences at p < 0.05 or lower between ε4 carrier and ε4 non-carrier in aMCI,
bHCS. – indicate no signiﬁcant group differences. cPearson’s X
2 test across diagnostic groups. dPearson’s X
2 test per diagnostic group. eAnalysis of covariance in
MCI, means adjusted for gender.
across accuracy scores from tests representing different cogni-
tive domains in HCS and AD (Lindenberger and Baltes, 1997;
Christensen et al., 1999; Brewster et al., 2012; MacDonald et al.,
2012) or in HCS, MCI and AD (Tractenberg and Pietrzak, 2011).
Even though IIV has been related to impaired cognitive con-
trol functions (MacDonald et al., 2009), we are not aware of
any study investigating IIV across accuracy scores from tests
uniquely representing cognitive control in these groups. Latency-
based IIV has been suggested to be a more sensitive measure
than accuracy-based IIV (Hultsch et al., 2000), and the direct
comparison of our results with work on latency-based IIV is
challenging. However, different studies have demonstrated a rela-
tionship between these measures (Hultsch et al., 2002; Hilborn
et al., 2009). Accordingly, increased latency- and accuracy-based
IIV have been linked to older age (Hultsch et al., 2002; West
et al., 2002; Lövdén et al., 2007; Hilborn et al., 2009), cogni-
tive decline (Kliegel and Sliwinski, 2004; Lövdén et al., 2007),
and to predict probable AD (Brewster et al., 2012) and incident
dementia (Holtzer et al., 2008). IIV has therefore widely been
accepted as a stable trait (MacDonald et al., 2006) - possibly reﬂect-
ing central nervous system integrity (MacDonald et al., 2009).
More precisely, evidence for a strong association between IIV
and frontal gray and white matter integrity (Stuss et al., 2003;
Lövdén et al., 2013), and evidence of changed gray and white
matter integrity in MCI and AD (Jackson et al., 2012; Yang et al.,
2012; Radanovic et al., 2013) support the idea of frontal system
disruptions underlying increased IIV in dementia (Jackson et al.,
2012).
It is beyond the aim of our study to draw direct inferences
about the origins of IIV. However, consistent with our hypothesis
and the literature (Tractenberg and Pietrzak, 2011; MacDonald
et al., 2012), we found increased across-domain IIV in AD vs.
HCS and in AD vs. MCI. Therefore, across-domain IIV was
similar in MCI and HCS. Even though others have examined
latency-based IIV within but not accuracy-based IIV across non-
cognitive control tasks (Tales et al., 2012), they have also reported
similar IIV in these groups. Moreover, MCI subjects who later
converted to dementia were found to have higher IIV than non-
converters. The absence of a group difference between MCI and
HCS in our study may therefore be related to a low proportion
of future converters in our MCI group. Additionally, and since
higher IIV has been found in tasks requiring cognitive control
(MacDonald et al., 2009), the requirement of cognitive control
processes in the tasks underlying across-domain IIV might have
been too limited to differentiate between these groups. Con-
sistent with this assumption, and consistent with the literature
on latency-based within-domain IIV (Duchek et al., 2009) we
found within-domain IIV, and hence IIV across tasks placing
more demands on cognitive control processes, being increased
in MCI vs. HCS. Considering impaired cognitive control func-
tions in MCI and AD (Schroeter et al., 2012), one might have
expected increased within-domain IIV in AD vs. MCI. Against
our expectations it was similar in both groups. Since the use
of a high number of trials has previously been proposed to
reliably detect IIV (Schmiedek et al., 2009), it might be less pro-
nounced when computed across three accuracy scores only, even
Frontiers in Aging Neuroscience www.frontiersin.org July 2014 | Volume 6 | Article 147 | 5
Kälin et al. Intraindividual variability in prodromal AD
when computed across cognitively demanding tasks as in our
study.
The similar difference scores in all groups offer additional sup-
port for increasing accuracy-based IIV across groups in general.
Though not signiﬁcantly different from the difference scores in
HCS and AD, it was very small in MCI (M = 0.005), reﬂecting
the increase in within-domain IIV/stability in across-domain IIV
between HCS and MCI. Due to the dependence of IIV on cogni-
tive control tasks, higher within- than across-domain IIV may be
expected. However, the higher across-domain IIV might be caused
by the early deterioration of episodic memory (Albert et al., 2011)
and short-term memory capacity (Schmitt et al., 2009) compared
to other cognitive domains in the disease process. Consequently,
and although mean performance was considered in the relevant
analyses, the use of a verbal learning task and a task assessing short-
termmemory capacitymight have triggered higher across-domain
IIV.
Additionally, we found increased within-domain IIV in HCS ε4
carrier vs. non-carrier, whereas there was no ε4-related change in
IIV in the other groups. Our result is consistent with ﬁndings from
Duchek et al. (2009) who have reported increased latency-based
IIV in a cognitive control task, but similar IIV in tasks without
cognitive control components in HCS ε4 carrier vs. non-carrier.
Since the frontal lobe constitutes a brain region that manifests ε4-
effects even early in the disease (Filbey et al., 2010), and is thought
to be at the basis of IIV (MacDonald et al., 2009), the present
ﬁndings offer further support for a relationship between within-
domain IIV and APOE status. It may, however, well be that ε4-
related change in IIV appears in HCS but may not be evident by
the MCI and AD stage.
The major limitation of our study is related to the selection
of the tasks. The limited number of available neuropsychologi-
cal tests did not allow applying factor analyses. Hence, the tasks
and their domain-relatedness were identiﬁed following the litera-
ture. Based on the high engagement of cognitive control processes,
we identiﬁed executive function tasks to calculate within-domain
IIV. However, cognitive control processes affect a wide range
of cognitive functions. This is why we aimed to identify tasks
placing low demands on cognitive control for across-domain
IIV, and tasks placing high demands on cognitive control for
within-domain IIV. This approach, however, revealed potential
confounding factors which make it difﬁcult to clearly determine
whether our results can be attributed to the fact that IIV was
calculated across vs. within-domain, or to the fact that the under-
lying tasks elicited low vs. high cognitive control. However, a
higher number as well as a wider range of neuropsychological tests
would be required to clearly differentiate between these aspects.
Hence, only cautious conclusions can be drawn based on our
results. Both aspects might be considered relevant with regard
to across-domain IIV. More precisely, similar across-domain IIV
between HCS and MCI is most likely based on equally reduced
cognitive abilities across domains in MCI (see Table 1). Although
cognitive control processes are expected to be impaired in pro-
dromal AD, the low level of cognitive control processes elicited by
these tasks may have been responsible for the uniformity of the
decrease. The impairment of cognitive control processes, how-
ever, may have been sufﬁcient to produce variation across tasks in
AD (e.g., unequally decreased test performances in AD vs. MCI,
see Table 1). In contrast, the aspect of high vs. low cognitive
control might be considered relevant with regard to within-
domain IIV. Increased within-domain IIV in MCI is most likely
based on unequally decreased performances in within-domain
IIV tasks (see Table 1). If it was the across vs. within-domain
aspect that was critical, equally decreased performances could
have been expected. Impaired cognitive control processes pro-
ducing inconsistencies across performances in cognitive control
sensitive tasks, and hence, producing higher within-domain IIV
in MCI seem more plausible. The further reduction of cogni-
tive control abilities in AD might lead to two different scenarios:
a) further increased within-domain IIV due to inconsistent test
performances or b) reduced within-domain IIV based on ﬂoor
effects. Since tasks with potential ﬂoor effects were excluded, the
latter does rather not apply. Although within-domain IIV did
not differ signiﬁcantly between MCI and AD, IIV was higher
in AD (Figure 1), indicating further increasing IIV. The lack
of a signiﬁcant difference might indeed have been caused by
the low sample size, and by the very subtle characteristic of
within-domain IIV in general. The ﬁnding of higher across- than
within-domain IIV across the groups in turn is most likely related
to inconsistent performances across tests representing different
cognitive domains. In summary, and although the present results
must be interpreted with caution, our results indicate that the
aspect of across vs. within domain might be most relevant for
the general characteristic of the IIV scores (higher across- than
within-domain IIV). In contrast, the aspect of high vs. low cog-
nitive control might be at the basis of within-domain IIV group
differences.
The minor limitations of our study are attributed to the
cross-sectional design. Our results, therefore, do not permit to
claim causality regarding the relationship between AD pathology
and IIV. More precisely, it has been argued that cross-sectional
data do not permit to clearly distinguish variability caused by
aging or neurodegeneration from stable individual characteris-
tics (Lindenberger and Potter, 1998). This risk was addressed by
treating age and within- and across-domain IIM as covariates
in all analyses. Furthermore, most test performances underly-
ing IIV were also used for diagnostic purpose, thus posing the
risk of circularity. However, we assume the risk to be min-
imal, since the outcome of interest in the present study was
the ISD calculated across tasks. In addition to that, neuropsy-
chological tasks that had not been used for IIV calculation,
wide-ranging medical information, and clinical evaluation also
contributed to the diagnosis. Another limitation is related to
the multidimensional nature of the neuropsychological tasks.
Although the tasks which were used to calculate within-domain
IIV place high demands on cognitive control processes, they
do not exclusively assess this particular cognitive function. Pro-
cessing speed (Greenaway et al., 2009), inhibition (Troyer et al.,
2006) and visuo-construction (Lezak et al., 2004) represent fur-
ther cognitive abilities that are crucial for successfully performing
the Letter Fluency task, the Stroop Test, and the Five-Point
Test, respectively. They might, therefore, represent potential con-
founders in the present study. Since the tasks which were used
to calculate across-domain IIV, however, place fewer demands
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on cognitive control processes than the task which were used
to calculate within-domain IIV, we assume this risk to be
reduced.
Despite these limitations, and although comparison with other
studies may be limited due to methodological differences among
studies (e.g., IIV deﬁnition and measures, diagnostic criteria), the
present study offers further support for increased IIV in MCI and
AD in general, and for increased accuracy-based IIV in partic-
ular. From a clinical point of view, accuracy-based IIV may be
more useful than latency-based IIV measures in everyday clini-
cal routine. First, tasks assessing cognitive control functions and
non-cognitive control functions are usually included in standard
clinical neuropsychological test batteries, and therefore allow IIV
calculations without applying additional tests. Second, assessing
accuracy-based IIV avoids the necessity to add multiple trials or
blocks of the same task to the standard test battery, and therefore
reduces the burden for the patients in dementia diagnostics. The
present study, therefore, underscores the importance of consider-
ing the value of IIV in the early detection of prodromal AD and
demonstrates the usability of accuracy-based IIV measures in AD
diagnosis. Both, across- and within-domain IIV may represent
potential cognitive markers for the early detection of prodromal
AD. However, further examination by using a higher number of
more complex tests in a longitudinal design is needed to provide
more speciﬁc information about the predictive value of these IIV
scores.
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